Ashton Thomas Private Wealth LLC bought a new position in Relx Plc (NYSE:RELX – Free Report) during the fourth quarter, Holdings Channel reports. The institutional investor bought 6,487 shares of the technology company’s stock, valued at approximately $295,000.
Other large investors have also recently bought and sold shares of the company. CENTRAL TRUST Co lifted its holdings in Relx by 1,290.2% in the fourth quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock worth $26,000 after acquiring an additional 529 shares during the last quarter. Versant Capital Management Inc bought a new position in Relx in the fourth quarter worth about $31,000. Sierra Ocean LLC bought a new stake in shares of Relx during the fourth quarter valued at approximately $43,000. Private Trust Co. NA raised its holdings in shares of Relx by 119.9% during the third quarter. Private Trust Co. NA now owns 1,038 shares of the technology company’s stock valued at $49,000 after buying an additional 566 shares during the last quarter. Finally, Whipplewood Advisors LLC bought a new stake in shares of Relx during the fourth quarter valued at approximately $74,000. Institutional investors own 15.02% of the company’s stock.
Relx Stock Performance
RELX opened at $47.25 on Wednesday. The business’s 50 day moving average is $48.69 and its 200-day moving average is $47.57. The stock has a market cap of $87.82 billion, a PE ratio of 25.41, a price-to-earnings-growth ratio of 2.73 and a beta of 0.90. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. Relx Plc has a twelve month low of $40.25 and a twelve month high of $51.99.
Relx Increases Dividend
Wall Street Analyst Weigh In
RELX has been the topic of a number of recent analyst reports. StockNews.com cut Relx from a “buy” rating to a “hold” rating in a report on Tuesday, March 4th. Redburn Atlantic initiated coverage on Relx in a report on Wednesday, January 8th. They set a “buy” rating on the stock.
View Our Latest Stock Analysis on RELX
Relx Company Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
See Also
- Five stocks we like better than Relx
- Technology Stocks Explained: Here’s What to Know About Tech
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- Want to Profit on the Downtrend? Downtrends, Explained.
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.